1. Home
  2. DFSCW vs MDAIW Comparison

DFSCW vs MDAIW Comparison

Compare DFSCW & MDAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DEFSEC Technologies Inc. Warrant

DFSCW

DEFSEC Technologies Inc. Warrant

N/A

Current Price

$0.02

Market Cap

0.0

Sector

Technology

ML Signal

N/A

MDAIW

Spectral AI Inc.

N/A

Current Price

$0.42

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DFSCW
MDAIW
Founded
N/A
N/A
Country
Canada
United States
Employees
30
78
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DFSCW
MDAIW
Price
$0.02
$0.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
35.6K
Earning Date
N/A
02-27-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$27,264,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
44.52
52 Week Low
N/A
$0.08
52 Week High
N/A
$0.90

Technical Indicators

Market Signals
Indicator
DFSCW
MDAIW
Relative Strength Index (RSI) N/A 44.44
Support Level N/A $0.38
Resistance Level N/A $0.48
Average True Range (ATR) 0.00 0.07
MACD 0.00 0.01
Stochastic Oscillator 0.00 54.76

Price Performance

Historical Comparison
DFSCW
MDAIW

About DFSCW DEFSEC Technologies Inc. Warrant

DEFSEC Technologies Inc is a canadian defence company. The company develops and commercializes next-generation tactical systems. The company offers breakthrough technology in lethal and non-lethal systems with broad application, including law enforcement and personal defence, modernized digitization of tactical forces for shared situational awareness and targeting, and counter-measures against threats such as drones, lasers, and electronic detection.

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: